ArticleAnnals of surgical treatment and research2025
The effect of enhanced recovery after surgery on postoperative delirium in surgical patients: a meta-analysis.
Article in Annals of surgical treatment and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Postoperative delirium (POD) is a frequent acute cognitive disorder that occurs after surgery. Enhanced recovery after surgery (ERAS) has been suggested to decrease its incidence. Due to the lack of conclusive evidence on the topic, we conducted a meta-analysis to investigate the potential impact of ERAS on POD. Methods: We included randomized controlled trials involving adult patients undergoing elective surgery. The ERAS group received management based on ERAS principles during the perioperative period, while the control group implemented traditional management strategies. The major evaluation indicators included the incidence of POD, the timing of its first occurrence, and the duration of POD. The secondary evaluation indicators were the content of Mini-Mental State Examination (MMSE) scores, the time to first ambulation, total complication rates, and length of hospital stay. Results: The results indicated that ERAS significantly reduced the overall incidence of POD (relative risk [RR] = 0.38, P < 0.00001) and the incidence of delirium on the first and second postoperative days (RR = 0.20, P = 0.03; RR = 0.21, P = 0.01). It also delayed the first occurrence of POD (mean difference [MD] = -1.5, P < 0.0001), reduced its duration (MD = -2.15, P = 0.005), improved MMSE scores (MD = 1.95, P < 0.00001), sped up ambulation (MD = -1.53, P < 0.00001), decreased total complication rates (RR = 0.21, P = 0.0003), and shortened hospital stays (MD = -4.61, P < 0.00001). Conclusion: In conclusion, ERAS significantly reduces POD and related complications while facilitating rapid recovery in surgical patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.